6月11日，Liquidia盘中上涨7.26%，报69.945美元/股，成交额5431.25万美元。
消息面上，Liquidia当日宣布将在PHA国际肺动脉高压会议暨科学大会上展示研究海报，显示公司在核心治疗领域的研发进展持续推进。该消息叠加近期股价强势表现——此前一周内公司股价已累计大幅上涨，市场对其肺动脉高压管线的关注度持续升温。
Liquidia所在的制药行业当日整体表现积极，辉瑞涨2.79%，礼来涨2.28%，默沙东涨1.53%，强生涨1.0%。Liquidia Corporation是一家生物制药公司，专注于肺动脉高压治疗领域，通过专有的PRINT粒子工程技术平台进行药物研发与商业化，该技术能精确生产均匀药物颗粒，应用于吸入疗法、疫苗、生物制剂等多种给药途径。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.